Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
Victor SsempijjaGertrude NakigoziLarry ChangRon GrayMaria WawerAnthony NdyanaboJingo KasuleDavid SerwaddaBarbara CastelnuovoAnja Van't HoogSteven James ReynoldsPublished in: BMC infectious diseases (2017)
Intervention strategies that aid clinicians to promptly switch patients to second-line ART as soon as virologic failure on 1st line ART is confirmed should be prioritized.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv infected patients
- hiv positive
- hiv aids
- end stage renal disease
- randomized controlled trial
- ejection fraction
- newly diagnosed
- prognostic factors
- type diabetes
- risk factors
- peritoneal dialysis
- palliative care
- patient reported outcomes
- cardiovascular events
- cardiovascular disease
- coronary artery disease